openPR Logo
Press release

Exploring the Booming D-Mannose Market: Trends and Opportunities

D-Mannose Market

D-Mannose Market

D-Mannose Market Outlook (2023-2033)
The sales from the global D-Mannose market is pegged at US$ 1,298.2 Million in 2023, and is estimated to reach US$ 1,680.5 Million by the end of 2033. Sales revenue is expected to register a CAGR of 2.8% over the forecast period (2023-2033).

The global D-mannose market is expected to grow significantly in the forecast period. D-mannose is a natural sugar that is found in various fruits, such as cranberries, apples, and oranges. It is commonly used as to treat urinary tract infections (UTIs) and other related conditions. The market is driven by factors such as the growing demand for natural and organic products, the increasing prevalence of UTIs, and the rising awareness about the health benefits of D-mannose.

Need More Insights on Competitor Analysis of the report, Request for Sample@ https://www.persistencemarketresearch.com/samples/32172

Market Drivers:
The growing demand for natural and organic products is a major driver of the D-mannose market. Consumers are becoming increasingly aware of the potential health benefits of natural and organic products, and are shifting away from synthetic products. D-mannose is a natural product and is therefore gaining popularity among health-conscious consumers.

Another driver of the D-mannose market is the increasing prevalence of UTIs. UTIs are a common health problem, particularly among women. D-mannose is known to be effective in preventing and treating UTIs, and is therefore becoming popular among people who suffer from these conditions.

The rising awareness about the health benefits of D-mannose is also driving the market. D-mannose is known to provide various health benefits, such as promoting healthy bladder function and supporting immune system function. As consumers become more aware of these benefits, the demand for D-mannose is expected to increase.

Market Restraints:
One of the main challenges for the D-mannose market is the availability of raw materials. D-mannose is primarily derived from cranberries, and the availability of cranberries can be limited, which can lead to price fluctuations.

If You want to Purchase Specific Insights By Segment/Region/Competitor, Request For Customization@ https://www.persistencemarketresearch.com/request-customization/32172

Segmentation:
The global D-mannose market can be segmented by source, form, application, and region.
• Based on source, the market can be segmented into cranberry-based and non-cranberry-based.
• Based on form, the market can be segmented into powder, capsule, and others.
• Based on application, the market can be segmented into UTI prevention and treatment, digestive health, immune support, and others.

Regional Analysis:
The global D-mannose market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America. North America is expected to hold the largest share of the market owing to the increasing prevalence of UTIs and the growing demand for natural and organic products in the region. Asia Pacific is expected to grow at a significant CAGR owing to the rising awareness about the health benefits of D-mannose in the region.

Competitive Landscape:
The global D-mannose market is highly competitive with key players such as
• Nestle Health Science
• NOW Health Group, Inc.
• Pfanstiehl Inc
• Vibrant Health
• Hanseler AG
• Source Naturals
• DuPont de Numerous, Inc.
• Bio-Tech Pharmacal
• Jarrow Formulas
• Nutraceutical International Corporation
• GNC Holdings, Inc.
• Swanson Vitamins
• Sweet Cures
• VWR Lab Products Private Limited
• NutriScience Innovations LLC
For instance, in February 2021, Jarrow Formulas launched a new D-mannose product called Jarro-Dophilus Women.

If You Want To Know The Business Opportunity/Market Value, Purchase The Premium Insight@ https://www.persistencemarketresearch.com/checkout/32172

The global D-mannose market is expected to witness significant growth over the forecast period owing to the growing demand for natural and organic products, the increasing prevalence of UTIs, and the rising awareness about the health benefits of D-mannose. However, the availability of raw materials can be a hindrance to market growth. The market is highly competitive with key players focusing on new product launches and strategic partnerships to expand their market share.

Read More Trending "PMR Exclusive Article":
• Edible Insects For Animal Feed Market Size - https://www.persistencemarketresearch.com/market-research/edible-insects-for-animal-feed-market.asp

• Pecan Market Share - https://www.persistencemarketresearch.com/market-research/pecan-market.asp

Contact Us:
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About us:
The Food & Beverage team at Persistence Market Research provides all the necessary insights and consulting analysis to fulfil the unique business intelligence needs of clients worldwide. With a catalogue of more than 500 reports pertaining to the latest statistics and analysis from the food & beverage industry, the team is happy to help with every business intelligence research and consulting requirement.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Exploring the Booming D-Mannose Market: Trends and Opportunities here

News-ID: 3163346 • Views:

More Releases from Persistence Market Research

Peptones Market to Reach US$ 512.5 Million by 2032 at 4.6% CAGR | Persistence Market Research
Peptones Market to Reach US$ 512.5 Million by 2032 at 4.6% CAGR | Persistence Ma …
The global peptones market size is valued at US$ 373.7 million in 2025 and is projected to reach US$ 512.5 million by 2032, growing at a CAGR of 4.6% between 2025 and 2032. Market growth is largely supported by expanding biotechnology research activities and increasing pharmaceutical production capabilities. Animal-based peptones remain among the leading product categories due to their extensive use in microbial cultivation. Geographically, North America leads the market
CMO/CDMO Biotechnology Market to Reach US$168.9 Billion by 2032 at 12.5% CAGR | Persistence Market Research
CMO/CDMO Biotechnology Market to Reach US$168.9 Billion by 2032 at 12.5% CAGR | …
The global CMO/CDMO biotechnology market size is likely to be valued at US$74.0 Billion in 2025 and is estimated to reach US$168.9 Billion by 2032, expanding at a CAGR of 12.5% during 2025-2032. The market is supported by increased investments in bioprocessing technologies, rising clinical trial activities, and growing demand for advanced therapeutic products. Biologics manufacturing services remain the leading segment due to increasing monoclonal antibody production. North America dominates
Medical Wellness Market to Reach US$3.7 Billion by 2032 at 10.6% CAGR | Persistence Market Research
Medical Wellness Market to Reach US$3.7 Billion by 2032 at 10.6% CAGR | Persiste …
The global medical wellness market size is expected to reach US$1.8 billion by 2025. It is estimated to reach US$3.7 billion by 2032, growing at a CAGR of 10.6% during the forecast period from 2025 to 2032. Increasing health consciousness, growing corporate wellness adoption, digital health integration, and demand for integrated healthcare experiences are supporting market growth. Wellness centers offering preventive screening, nutrition planning, stress management, and personalized care are
Acne Treatment Market to Reach US$ 11,825.1 Mn by 2032 at 6.1% CAGR | Persistence Market Research
Acne Treatment Market to Reach US$ 11,825.1 Mn by 2032 at 6.1% CAGR | Persistenc …
The global market for acne treatment is estimated to value at US$ 11,825.1 Mn by the end of 2032 from US$ 7,812.6 Mn recorded in 2025. The market is expected to secure a CAGR of 6.1% in the forthcoming years from 2025 to 2032. Growing incidences of hormonal disorders, increasing urbanization, changing dietary patterns, and rising stress levels are contributing to acne prevalence worldwide. Topical medications continue to represent a

All 5 Releases


More Releases for UTI

Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl …
Introduction The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve. This article explores the key factors driving the
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE …
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc. Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders. Houston, TX based Patterson-UTI
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report: The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract